Status:

UNKNOWN

Combined Administration of Intravenous and Topical Tranexamic Acid in Total Knee Arthroplasty

Lead Sponsor:

Seoul National University Hospital

Conditions:

Degenerative Arthritis

Eligibility:

All Genders

50+ years

Phase:

PHASE1

Brief Summary

This prospective randomized controlled trial was conducted To compare the efficacy of TNA in terms of total blood loss and the allogenic transfusion rate among the three study groups; intravenous alon...

Eligibility Criteria

Inclusion

  • patients with diagnosis of primary osteoarthritis

Exclusion

  • patients with diagnoses other than primary OA
  • patients on anticoagulation therapy
  • patient with chronic renal failure
  • patient with CVA Hx
  • Patient with seizure Hx
  • Patient with severe CHF
  • Patient with acquired or congenital coagulopathy

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2015

Estimated Enrollment :

264 Patients enrolled

Trial Details

Trial ID

NCT02286973

Start Date

November 1 2014

End Date

June 1 2015

Last Update

November 10 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Combined Administration of Intravenous and Topical Tranexamic Acid in Total Knee Arthroplasty | DecenTrialz